Mutations in the VMD2 gene cause Best's disease, an inherited form of macular degeneration. The reduction in the light-peak amplitude in the patient's electro-oculogram suggests that bestrophin-1 influences the membrane conductance of the retinal pigment epithelium (RPE). Systemic application of the L-type Ca 2+ channel blocker nimodipine reduced the light-peak amplitude in the rat electroretinogram but not a-and b-waves. Expression of bestrophin-1 in a RPE cell line (RPE-J) led to changes in L-type channel properties. Wild-type bestrophin-1 induced an acceleration of activation kinetics of Ba 2+ currents through L-type Ca 2+ channels and a shift of the voltage-dependent activation to more negative values, closer to the resting potential of RPE cells. Expression of bestrophin-1 with Best disease-causing mutations led to comparable shifts in voltage-dependent activation but different effects on activation and inactivation kinetics. Bestrophin W93C exhibited slowed activation and inactivation, and bestrophin R218C accelerated the activation and inactivation. Thus, transfection of RPE cells with bestrophin-1 distinctively changed L-type Ca 2+ channel kinetics and voltage-dependence. On the basis of these data, we propose that presence of bestrophin-1 influences kinetics and voltage-dependence of voltage-dependent Ca 2+ channels and that these effects might open new ways to understand the mechanisms leading to retinal degeneration in Best's disease. est's vitelliform macular dystrophy is an autosomal dominant inherited form of macular degeneration with similarities to age-related macular degeneration (1-3). The disease is characterized by an early onset and a reduction in the light-peak in patients electrooculogram (EOG) (1).
est's vitelliform macular dystrophy is an autosomal dominant inherited form of macular degeneration with similarities to age-related macular degeneration (1) (2) (3) . The disease is characterized by an early onset and a reduction in the light-peak in patients electrooculogram (EOG) (1).
Best's disease is caused by mutations in the VMD2 gene (4) (5) (6) (7) (8) (9) (10) (11) (12) . The gene product of VMD2, bestrophin-1, is known to be exclusively expressed in the RPE (13) . There, bestrophin-1 is localized to the basolateral plasma membrane (13) and interacts physically with protein phosphatase 2A (14) . Bestrophin-1 belongs to the family of RFP-domain (an invariant argininephenylalanine-proline tripeptide) proteins (11, 15) . Four members of this family are known (11, 16) . Expression studies in HEK 293 cells indicated that bestrophin-1 and other RFP family members function as Ca 2+ -dependent Cl -channels (17) (18) (19) (20) (21) . To date, all disease-causing mutations in bestrophin-1 reportedly have led to a loss of Cl -channel function with a dominant negative effect (17) . These observations are proposed to explain the reduction in the EOG lightpeak that is diagnostic for Best's disease.
The light peak is thought to arise from a substance designated "light-peak substance", which is released from inner layers of the retina in response to a light stimulus (22) (23) (24) (25) . The identity of the light-peak substance is unknown. However, a leading candidate is ATP. The light-peak substance diffuses to the RPE, which presumably activates a signal transduction cascade. On the basis of studies of ATP stimulation, this most likely involves the inositol-1,4,5-trisphosphate/Ca 2+ second-messenger system. In consequence, the Cl -conductance across the basolateral plasma membrane is increased (22) . Because of the high intracellular Cl -activity between 40 and 60 mM (22, 26, 27) , the equilibrium potential for Cl -is approximately in the range between -30 and -20 mV, which is more positive than the reported resting potential between -45 and -40 mV in RPE cells (26, 27) . The increased basolateral Cl -conductance causes a depolarization of the basolateral membrane, which can be recorded as the light-peak amplitude (24) . Although the Cl -conductance, which generates the light peak substance has been proposed to be Ca 2+ sensitive, that hypothesis has never been experimentally tested. We have shown that RPE cells express L-type Ca 2+ channels and that these channels provide a route by which extracellular Ca 2+ enter the cell and lead to the activation of Cl -channels in response to an increase in intracellular inositol-1,4,5-trisphoshate (28) .
On the basis of the hypothesis that bestrophin-1 represents the Ca 2+ -dependent Cl -channel activated by the light-peak substance, it has been proposed that the loss of Cl -channel function in the mutant forms of bestrophin-1 directly leads to the primary symptom of Best's disease, a diminished light peak. However, characterization of patients with new VMD2 mutations indicates that bestrophin-1 might not only function as a Cl -channel (29) (30) (31) (32) (33) (34) . These studies described patients with late-onset vitelliform macular degeneration, patients who show the onset of light-peak reduction after the onset of clinically identifiable macular degeneration or patients with normal light-peak. These observations have been made with patients carrying mutations that have been already published or so far unknown mutations. Furthermore, we have recently shown that overexpression of bestrophin-1 in the rat did not increase maximum light-peak amplitude but rather altered the kinetics of light-peak activation and the light sensitivity of the response (35) .
To identify other ion channels involved in the generation of the light peak, we performed lightpeak measurement in the rat DC-electroretinogram (ERG). To correlate these findings with B (13, 36) . Our findings suggest that bestrophin-1 alters several aspects of L-type Ca 2+ channel activity in RPE cells.
MATERIALS AND METHODS

Conventional ERG recordings
Rat DC-ERGs were recorded from both eyes simultaneously in response to strobe flashes ranging from -3.6 to 2.1 log cd s/m 2 using a standard protocol (37) . For ERG recordings, animals were kept under anesthesia using ketamine/xylazine (50 mg/kg and 2 mg/kg) as described previously (38) . Rat experiments were performed in accordance to ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. The amplitude of the a-and b-waves was measured conventionally and the b-wave intensity-response function was analyzed using the Naka-Rushton Eq. (39) . Recordings of the light peak (LP) were made as described previously (38) . The LP was recorded in response to a 5-min stimulus. The recorded signals were: c-wave followed by a negative fast oscillation and subsequent slowly developing signal in positive direction, the LP. From the baseline, the LP appeared as a signal in the negative voltage range. LP amplitudes were determined by analysis of the absolute minimum and maximum values. Grand averages were derived by averaging all waveforms within each experimental group.
Cell culture and transfection
The rat RPE cell line RPE-J was purchased from ATCC. Cell culture and transfection. RPE-J cells were cultured in Dulbecco's Minimal Essential Medium (DMEM supplemented with 4% fetal calf serum). The cultures were maintained at 32°C and 5% CO 2 in air, and the medium was changed twice a week. Confluent cells were split in the ratio 1:2 using the trypsin/EGTA method. Subconfluent cultures were transfected using lipofectamine (Invitrogen) according to manufacturer's instructions. The total amount of DNA per well (∅ 1.5 cm) was 0.4 μg. Cotransfection of different bestrophins with eGFP was performed in a ratio of 4:1. Successful transfection of cells was monitored by fluorescence microscopy. Transfection efficiency ranged from 60 to 80%. Transfection efficiency was the same with either WT bestrophin-1, eGFP, W93C, or R218C. Transfected cells were investigated between 24 and 72 h after transfection. During this time, no decrease in transfection rate could be observed.
Plasmid constructs
All different bestrophins were cloned into pCDNA3.1. The plasmid pCDNA3.1-Best and the cloning method were described previously (13) . The W93C and R218C mutants of bestrophin-1 were produced using the QuickChange site-directed mutagenesis method (Stratagene).
Patch-clamp recordings
Patch-clamp recordings were made in the perforated patch configuration as described previously (40, 41 -concentration was adjusted to 10 nM. Membrane capacitance and access resistance were compensated for by the patchclamp amplifier. In a minority of cells, membrane capacitance could not be fully compensated for because of space clamp artifacts. These cells were excluded from kinetic analysis.
To activate currents through L-type channels, the cells were depolarized from a holding potential of -70 mV. Depolarization consisted of 9 voltage steps of 50-ms duration and 10-mV increasing amplitude. Kinetic analysis of current data was performed as indicated in Table 1 . Voltagedependent activation was analyzed by plotting current amplitudes normalized to maximal current amplitude vs. test potential. The resulting curve was fitted using the Boltzmann equation, and corresponding fits were made for each cell. To compare the voltage-dependent activation between the cells, we used the potentials of the half-maximal activation, which were calculated from the Boltzmann fits. Activation kinetics, inactivation time constants, and maximal current amplitudes were estimated from currents activated by a voltage step from -70 mV to +10 mV. As an easy and reliable method, activation kinetics were evaluated by measurements of the time to peak of the current at +10 mV. To compare the activation kinetics with published data from other groups, some of the currents were analyzed by calculation of the activation time constant according to the method used by Koschak et al. (42) .
Western blot analysis
Western Blot analyses were performed as described previously in detail (43) . Membrane lysates of confluent RPE-J cells were established. To the lysis buffer (20 mM Tris, 5 mM MgCl 2 , 1 mM EDTA, 0.3 mM EGTA) protease inhibitiors (16 µg/ml benzamidine-HCl, 10 µg/ml phenanthroline, 10 µg/ml leupeptin, 10 µg/ml pepstatin, 174 µg/ml phenylmethylsulfonylflouride, 1 µg/ml aprotinine) were added to avoid degrading processes. After three freezing and thawing steps (liquid N 2 ; 42°) and two centrifugation steps at 500 and 43,000 g, the pellet was suspended in lysis buffer and subjected to SDS-PAGE (8.5% gel), and the proteins were blotted to nitrocellulose filter membranes (Polyscreen; NEN Life Science Products, Boston, MA). After blocking in 5% nonfat dry milk and 5% bovine serum albumin and incubation with primary antibodies, blots were finally visualized with a peroxidase-conjugated secondary antibody and a chemiluminescence kit according to manufacturer's instructions (Lumi light Western blotting substrate, Roche). The images were digitized using an image analyzer (Fujifilm; LAS 1000; Fuji, Tokyo; Japan) and suitable software (Aida 2.1; Raytest, Berlin, Germany). Anti-Ca V 1.2 and anti-Ca V 1.3 antibodies were purchased from Alomone Laboratories (Jerusalem, Israel).
RT PCR
Total RNA was extracted from RPE cells using the RNeasy Mini Kit (Qiagen) according to the manufacturer's protocol. The RNA (1 µg) was reverse transcribed at 37°C for 1 h in the following reaction mixture: 1 µg oligo dT primer (Invitrogen), 1 mM of each dNTP, 20 U RNAguard (Amersham Biosciences), 20 U M-MLV reverse transcriptase (Invitrogen). For control PCR reactions, human total brain RNA (Stratagene) was reverse transcribed under the same conditions. PCR amplification was performed in a reaction mix containing 0.5 µl cDNA, 15 pmol of each amplification primer, 0.2 mM of each dNTP, and 5 U Taq DNA polymerase. Forty cycles with three temperature steps were used for amplification (94°C, 62°C, 72°C for the exons 11 and 44, and 94°C, 60°C, 72°C for the exon 32). The primers used were for exon 11 forward 5`-acggggagatttccagaagctc-3` and reverse 5`-ggctgattgtagtgctcagagga-3`, for exon 32 forward 5`-gatgccatggacattctgaacatg-3` and reverse 5`-gaggagggccacatacgggag-3` and for exon 44 forward 5`-gcattgggaacctcgagcatgtgtctg-3` and reverse 5`-gcgagctgtcatcctcgtagc-3`. Amplified DNA fragments were analyzed by agarose gel electrophoresis and sequenced.
Protein localization by biotinylization
RPE-J cells were cotransfected to express GFP and one of the following: empty vector, bestrophin-1, bestrophin-W93C, or bestrophin R218C. After 24 h, cells were surface-biotinylated using sulfo-NHS-LC-biotin as described previously (44) . After biotinylation, bestrophin-1 or GFP were immunoprecipitated, and the immunoprecipitates blotted as described previously (13) with streptavidin conjugated to alkaline phosphatase or monoclonal antibodies recognizing bestrophin 1 (E6-6) or GFP (Clontech) followed by alkaline phosphatase conjugated goat antimouse IgG. Blots were developed using TNBT and BCIP and photographed using a BioRad Chemidoc imaging workstation.
Calculations and statistical analysis
Data are presented as mean ± SEM and were analyzed for significance using ANOVA. Significance was assumed at the P values of *P < 0.05, **P < 0.01, and ***P < 0.001 with Sigma-plot software (Sigma Plot Scientific Graph System, Version 1.02, Jandel, San Rafael, CA). Mean values of data from Boltzmann fits were calculated from individual fits for each experiment. All Western blot experiments were performed 3−4 times. Figure 2 shows one representative experiment.
RESULTS
Presence of L-type channels in the RPE: effects of nimodipine on the light peak
To determine whether RPE L-type Ca 2+ channels participate in generating the light peak, we analyzed the effects of nimodipine, a specific inhibitor of L-type voltage gated Ca 2+ channels, on RPE-derived ERG components recorded from rats ( Fig. 1) . Nimodipine is known to inhibit Ltype channels without having systemic cardiovascular site effects.
Rats were injected with nimodipine (1 mg/kg or 2.4 µmol/kg body weight) and dark adapted for 30 min, after which ERGs were recorded in response to a 5 min 2.7 log cd m -2 stimulus. As shown in Fig. 1B , RPE generated ERG components were smaller in nimodipine-treated animals than in vehicle-treated controls. In comparison, a-and b-waves were unaffected in rats receiving nimodipine (Fig. 1A, C, D) , indicating that the reduction in RPE generated components, induced by nimodipine was not due to suppression of phototransduction. An effect on the c-wave was not observed. On average, LPs in animals treated with nimodipine (n=8 in each group) were reduced by 35% (P<0.01) compared with animals treated with vehicle alone (Fig. 1E) , indicating a significant role for L-type Ca 2+ channels in determining LP amplitude.
RPE-J cells express L-type channels
To dissect the potential for bestrophin-1 to affect L-type Ca 2+ conductance, we choose to examine RPE-J cells. First, we determined whether RPE-J cells express L-type channels using whole cell patch-clamp experiments. In the presence of 10 mM Ba 2+ in the bath solution, RPE-J cells responded to depolarization from a holding potential of -70 mV with fast activating and inactivating inward currents (Fig. 2B) . These currents activated at potentials more positive than -30 mV (potential of the half-maximal activation was -14.0 ± -0.7; n=19) and reached maximal current amplitudes at +10 mV (Fig. 2D) . The current peak was reached after 4.7 ± 0.6 ms (n=16), which corresponds to activation time constant of 0.2 ± 0.06 ms (n=6). The maximal current density of these currents was 5.7 ± 0.9 pApF -1 (n=16). Application of the L-type Ca 2+ channel blocker nifedipine at a concentration of 10 µM reduced the currents to 34.7 ± 4.6% (n=5; P<0.00001) of the control value observed before nifedipine application (Fig. 2C) . Nifedipine did neither change the voltage dependence of the currents (potential of the half-maximal activation in the presence of 10 µM nifedipine: -16.0±2.5 mV; n=3) nor the activation kinetics (time to peak 10 µM nifedipine: 5.16 ± 0.8 ms; n=3). Western blot analysis of membrane proteins from RPE-J cells indicated that RPE-J cells express Ca V 1.3 Ca 2+ channel subunits (Fig. 2E) . Thus, RPE-J cells express L-type channels of the neuroendocrine subtype but not of the cardiac subtype. The expression of Ca V 1.3 subunits was confirmed by RT-PCR analysis, which revealed the expression of a splicing variant, including the exons 11, 32, and 44 ( Fig. 1F) .
Transient expression of wild-type bestrophin-1
After transfection of RPE-J cells with WT-bestrophin-1 or the two mutants W93C and R218C, these different bestrophins were found to be localized in the cell membrane (Fig. 3A) . Expression of eGFP alone in RPE-J cells did not affect either voltage-dependence nor Ba 2+ current kinetics ( Table 1) . Coexpression of eGFP together with wild-type bestrophin-1 led to faster activation kinetics (Fig. 3B, C) measured as time to peak (P<0.0002; Fig. 4B, 5A ). In addition, the voltagedependent activation of Ba 2+ currents in bestrophin-1 and eGFP cotransfected cells was shifted to more negative values (P<0.00001; Table 1 , Fig. 4A ). The membrane localization of the different bestrophins was verified by biotinylization assay (Fig. 3A) . Comparable observations were made when the eGFP-bestrophin-1 fusion construct was used (Fig. 3 D, E) . This construct enabled us to verify that the above-described changes in L-type channel activity were observed in cells showing the bestrophin-1 in the cell membrane (Fig. 3D) . In these cells, bestrophin-1 transfection led to faster activation kinetics, as well as to a shift of the voltage-dependent activation to more negative values (Fig. 5) . In both sets of experiments, bestrophin-1 did not alter L-type channel amplitude, the maximal current density remained unchanged ( Table 1) . Application of nifedipine (10 µM) reduced the Ba 2+ currents in transfected cells to 33.0 ± 4.3% (n=4) of the control amplitude observed before application of nifedipine. Faster activation kinetics were observed at all membrane potentials at which Ca 2+ channel currents were measured (4 B). Thus, the presence of wild-type bestrophin-1 led to modulation of L-type Ca 2+ channel 
Effects of mutant bestrophin-1
In this study, we concentrated on the two most frequently described mutants of bestrophin-1 associated with Best's disease, W93C and R218C (www.uni-wuerzburg.de/humangenetics/ vmd2.html). In our first set of experiments, effects of the mutant W93C were investigated (Fig.  6B) . In RPE-J cells transfected with W93C-bestrophin activation and inactivation kinetics were several-fold slower than in nontransfected cells (P<0.0003; Fig. 6A, B) or cells transfected with wild-type bestrophin-1 (P<0.0002; Fig. 6A, B) . However, the shift in the voltage-dependent activation to more negative values was comparable to that observed with wild-type bestrophin-1 (Fig. 6D) . Because of the slow inactivation in the presence of W93C bestrophin, after 50 ms a rest steady state current of 40% of the maximal current amplitude remained in cells transfected with W93C bestrophin, which is threefold higher than in cells transfected with wild-type bestrophin-1 or in untransfected cells (P<0.00005).
The mutant R218C had different effects on L-type channel activity (Fig. 6C) . RPE-J cells transfected with R218C bestrophin showed L-type Ba 2+ currents with voltage-dependent activation (Fig. 6D ) and activation kinetics comparable to cells, which have been transfected with wild-type bestrophin-1 (Fig. 6A) . However, this mutant influenced L-type channel inactivation (Fig. 6C) . In cells transfected with R218C, the currents inactivated significantly faster than with wild-type bestrophin-1 (P<0.02) or in untransfected cells (P<0.001). In contrast to control cells or cells transfected with wild-type bestrophin-1, L-type channels in RPE-J cells transfected with R218C bestrophin inactivate completely (Table 1) . Both mutant bestrophins affected another characteristic of L-type Ca 2+ channels. RPE-J cells transfected with either R218C or the W93C mutants showed a severe rundown of L-type channel activity in the perforated-patch configuration (Fig. 6E ).
DISCUSSION
Bestrophin-1, the product of the VMD2 gene, is expressed only in RPE cells. This is the first study of bestrophin-1 that has thoroughly characterized the effects of bestrophin-1 on ion transport in an RPE-derived cell line. To date, all previous studies have almost completely relied on data derived from exogenous expression in HEK 293 cells. Of significant interest, we find that when expressed in RPE-derived cells, bestrophin-1 altered the characteristics of L-type Ca 2+ channel activity, suggesting that bestrophin-1 plays a role in regulation of Ca 2+ entry via L-type Ca 2+ channels.
Systemic application of the L-type channel blocker nimodipine did not affect the ERG a-and bwaves, which arise from activation of photoreceptors and the neural retina. This is in accordance with other ERG studies using dihydropyridine compounds to inhibit L-type channels. Instead, nimodipine selectively affected a RPE-generated ERG components, the light peak. It is likely that nimodipine cannot pass through the blood-retina barrier and affects only L-type channels in the RPE. In addition, the c-wave, another signal which originates in the RPE, is unchanged. However, this is likely because the c-wave results from hyperpolarization of the apical membrane (27) . L-type Ca 2+ channels are activated by depolarization. In summary, in vivo the
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RPE require L-type Ca 2+ channels to properly generate the light peak. Furthermore, this is the first demonstration that L-type Ca 2+ channels play a functional role in the RPE of an intact eye.
Depolarization of RPE-J cells in the presence of extracellular Ba 2+ led to activation of voltageand time-dependent inward currents. By means of voltage dependence and sensitivity to the dihydropyridine nifedipine, these currents could be identified as currents through L-type Ca 2+ channels (45, 46) . This observation is in accordance with investigations of cultured or freshly isolated RPE cells from various species (47-53). The dihydropyridine nifedipine neither changed activation kinetics nor voltage dependence. Thus, it is likely that a main portion of the current is carried by L-type channels. The currents showed fast activation kinetics, relatively negative activation thresholds, and a rather low dihydropyridine sensitivity. With an activation time constant of 0.2 ms and a potential of half-maximal activation at -14 mV currents through L-type channels in RPE cells are comparable with currents of Ca V 1.3 Ca 2+ channel subunits in heterologous expression studies (42, 54, 55 ) and native cells (56). In the presence of nifedipine, a rest current of ~40% of the control current was measured. This seems to be a difference to Ca V 1.3 channels in the expression system (42) but seems to be characteristic for these channels in native cells (56). However, the currents in RPE cells show a relative fast inactivation compared with Ca V 1.3 currents in heterologous expression or in native cells. This might be a characteristic of the splicing variant expressed in RPE cells (57). So far, this variant has not been published, and its characteristics are unknown. The expression of these Ca 2+ channel subunits in RPE-J cells was confirmed by Western blot analysis. Here, Ca V 1.3 could be detected but not Ca V 1.2. The expression of the skeletal subtype or the photoreceptor-specific subtype is unlikely (46, 58) . In studies of human or rat cells, this Ca 2+ channel subunit appeared as the predominant Ca 2+ channel subunit in the RPE (51-53). Thus, the L-type channels in RPE cells are predominantly L-type channels of the neuroendocrine subtype.
Using a biotinylization assay, we demonstrated that heterologously expressed bestrophin-1, the mutant W93C and the mutant R218C are localized in the cell membrane. RPE-J cells transfected with wild-type bestrophin-1 showed L-type channel currents with different characteristics. The current density was comparable to that of untransfected cells but activated at more negative potentials and showed faster activation kinetics. The faster activation kinetics could be observed at all potentials at which Ca 2+ channels were active. Thus, the changes in activation kinetics were not due to the shift in the voltage-dependent activation. These effects were seen when bestrophin-1 was either coexpressed with eGFP as reporter or when an eGFP-bestrophin-1 fusion construct was used. eGFP alone had no effects on L-type channel activity. Furthermore, the eGFP-bestrophin-1 fusion construct permitted us to correlate the bestrophin-1 localization with effects on L-type channel activity. The effects we describe here were observed in cells where bestrophin-1 was localized at the plasma membrane. On the basis of these data, we propose that the presence of bestrophin-1 results in specific changes in the activity of L-type channels. This hypothesis is supported by the investigation of the effects of mutant bestrophins. Both mutants investigated had no effects on the current density but shifted the voltage-dependent activation to more negative values similar to that in cells transfected with wild-type bestrophin-1. However, both the R218C and W93C mutants demonstrated different effects on L-type channel kinetics. W93C slowed down both activation and inactivation kinetics, whereas R218C only affected the inactivation kinetics. Thus, bestrophin-1 affects L-type channel activation kinetics and voltage dependence. The mechanism underlying these effects requires further evaluation. The observed bestrophin-dependent changes in the L-type channel characteristics are comparable to those One effect of bestrophin-1 expression, which was identical regardless of mutation, was a shift of voltage-dependent activation to more negative values, closer to the approximate resting potential of RPE cells. This shift may serve to enable L-type channels in RPE cells to contribute to rises in intracellular free Ca 2+ as second-messenger at rather negative membrane potentials (40) , close to the resting potential of RPE cells of -40 to -45 mV (26, 27) . This is a property that has been described for Ca 2+ channels of Ca V 1.3 subtype (42), and bestrophin-1 might facilitate this. Furthermore, prior studies on the regulation of L-type channels in the RPE have suggested that modulation of the voltage dependence to increase the number of active channels near the resting potential of RPE cells may be more important to generate rises in intracellular-free Ca 2+ than depolarization of RPE cells (40) . Failure to properly regulate the exchange of Ca 2+ resulting from these responses could lead to uncontrolled changes in Ca 2+ homeostasis.
Best's vitelliform macular dystrophy is associated with a decrease of the light peak in patient's EOG (1) . Systemic inhibition of L-type channels reduced the light-peak amplitude. Secondmessenger dependent activation of L-type channels increases intracellular-free Ca 2+ (40) and subsequently activates Ca 2+ -dependent Cl -channels (28) . Thus activation of L-type Ca 2+ channels likely contributes to the generation of the light-peak peak conductance. The bestrophindependent changes in L-type channel properties must lead to corresponding changes in the light peak. Transfection of the rat RPE with wild-type bestrophin-1 in an animal model for Best's disease did not change the light-peak amplitude but accelerated the rise of the light peak (35) . The mutant W93C led to slower rises in the light peak, and the mutant R218C had the same effect on the rise of the light peak as wild-type bestrophin-1 but the light-peak amplitude was much smaller (35) .
In previous publications, bestrophin-1 has been described as a Ca
2+
-dependent Cl -channel (17, 21) . Using site-directed mutagenesis, properties of the channel pore of bestrophin-2 were characterized. However, recent reviews state that the picture of bestrophin as a Cl -channel is not complete (59, 60) . We found that the expression of bestrophin-1 leads to changes in the activity of L-type Ca 2+ channels. These functions are not mutually exclusive, and it is possible that bestrophin might combine the function as Cl -channel and Ca 2+ channel regulator and brings both ion channel types into synergistic function. For instance, the combination of these functions could establish a direct feedback loop for activation of Ca 2+ -dependent Cl -channel in the presence of L-type channels. Our data imply disturbed Ca 2+ homeostasis as an additional factor in the chain of events leading Best's macular dystrophy. Thus, the effects on Ca 2+ channel activity might open new ways to understand the heterogeneity between onset of macular degeneration and reduction of the light-peak in Best's macular dystrophy (4-6, 9, 12, 29, 30, 32-34, 61 and one of the following: empty vector (sham), bestrophin-1 (wt), bestrophin-W93C (W93C), or bestrophin R218C (R218C). After 24 h, cells were surface biotinylated. After lysis, bestrophin or GFP were immunoprecipitated as indicated and blotted for biotin using streptavidin, for bestrophin using an anti-Best-1 monoclonal antibody, or for GFP using an anti-GFP monoclonal antibody. Note that wt, W93C, and R218C forms of bestrophin were biotinylated, and so were present on the cell surface in contrast to GFP, an intracellular protein. Maximal current amplitude (normalized to the amplitude, which has been measured directly after the establishment of the perforated-patch configuration) was plotted over the experiment time. Membrane resistance and membrane capacitance remained unchanged during this time. L-type currents in cells transfected with wild-type bestrophin-1 (circles) were stable for more than 10 min; with either W93C (triangles) or R218C bestrophin (squares), the currents were stable for only 2-3 min and then showed severe run-down. The most unstable recording was with R218C. . Data are presented as mean ± SE and were analyzed for significance using ANOVA. Significance was assumed at *P < 0.05; **P < 0.01, and ***P < 0.001.
